Home
Products
Learn
About
Pricing
Log In
PLRX
Asset Logo

Pliant Therapeutics Inc

🇺🇸 NYSE/NASDAQ

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-19.14%
Annual Growth

5 years average annual capital growth

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Pliant Therapeutics, Inc. is a late-stage biotechnology company, which is focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. The Company’s lead product candidate, bexotegrast (PLN-74809), is an oral, small molecule, dual selective inhibitor of avb6 and avb1 integrins that is in development in the lead indication for the treatment of idiopathic pulmonary fibrosis, or idiopathic pulmonary fibrosis (IPF). The Company’s second clinical program, PLN-101095, is a small molecule, dual selective inhibitor of integrins avb8 and avb1 for the treatment of solid tumors that are resistant to immune checkpoint inhibitors. Its Phase 1-ready program PLN-101325, is in development for treatment of muscular dystrophies, including Duchenne muscular dystrophy. PLN-101325 is a monoclonal antibody designed to act as an allosteric agonist of integrin a7b1.

📈 Performance

Price History*

-93.31%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$1.46

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in PLRX

0

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

27 weeks

💵 Average investment amount

$2,000

Last time a customer invested in PLRX

67 days
PLRX investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

🙋 Legal gender of investors

Female

Male

Pearlers who invest in PLRX also invest in...

Akero Therapeutics Inc

AKRO

🙌 Performance (5Yr p.a)

15.97%

📊 Share price

$37.64 USD

📈 HIGH PRICE GROWTH

Find Out More

📊 Share price

$1.25 USD

🙌 Performance (5Yr p.a)

-16.09%

📊 Share price

$1.26 USD

🙌 Performance (5Yr p.a)

45.74%

📊 Share price

$43.06 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

-19.20%

📊 Share price

$0.36 USD

Want more shares? Try these...

📊 Share price

$0.36 USD

🙌 Performance (5Yr p.a)

45.29%

📊 Share price

$136.91 USD

📈 HIGH PRICE GROWTH

Compare
Add to watchlist